Usage of eribulin and vinorelbine in the treatment of breast cancer – two case reports
MUDr. Zuzana Donátová
Onkologická klinika 1. LF UK a Thomayerovy nemocnice, Praha
Breast cancer in metastatic stage is considered as incurable disease. About 20% of all patients have distant metastases. The offer of new cytotoxic and biological agents caused prolongation of the overall survival in patients with metastatic disease. Eribulin is considered as the new effective cytotoxic agent for pre-treated patients with locally recurrent and metastatic breast cancer. Vinorelbin is effective well tolerated treatment, which is important in sequence palliative treatment of metastatic breast cancer.
breast cancer, eribulin, vinorelbin, quality of life
The full article is only available to subscribers
Become a regular subscriber to our Oncological Review...